VI. Uterussarkom

Literatur
1. Abu-Rustum N.R., Curtin J.P., Burt M., Jones W.B.: Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy. Obstet Gynecol 1997; 89:850-852
2. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Jr.: Treatment of endometrial stromal tumors. Gynecol Oncol 1990 Jan; 36 (1):60-65
3. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Jr.: Treatment of uterine leiomyosarcoma. Obstet Gynecol 1988 Jun; 71 (6 Pt 1):845-50
4. Bodner K., Bodner-Adler B., Obermair A. et al.: Prognostic parameters in endometrial stromal sarcoma: a
clinicopathologic study in 31 patients. Gynecol Oncol 2001; 81:160-165
5. Brooks S.E., Zhan M., Cote T., Baquet C.R.: Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol 2004; 93:204-208
6. Burns B., Curry R.H., Bell M.E.: Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases. Am J Obstet Gynecol 1979; 135:109114
7. Chang K.L., Crabtree G.S., Lim-Tan S.K., Kempson R.L., Hendrickson M.R.: Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990; 14:415-438
8. Demetri G.D., Chawla S.P., von Mehren M. et al.: Efficacy and safety of trabectedin in patients with advanced and metastastic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol 2009; 27:4188-4196
9. Edmonson J.H., Blessing J.A., Cosin J.A., Miller D.S., Cohn D.E., Rotmensch J.: Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study. Gynecol Oncol 2002; 85:507-510
10. Evans H.L., Chawla S.P., Simpson C., Finn K.P.: Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988; 62:2239-2247
11. FIGO committee on Gynecologic Oncology. FIGO staging for uterine sarcomas. Int JGynecol Obstet 2009; 104:179
12. Gadducci A., Sartori E., Landoni F., Zola P., Maggino T., Urgesi A., Lissoni A., Losa G., Fanucchi A.: Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996; 63:247-253
13. Giuntoli R.L. 2nd, Metzinger D.S, . DiMarco C.S., Cha S.S., Sloan J.A., Keeney G.L., Gostout B.S.: Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 2003; 89:460-469
14. Goff B.A., Rice L.W., Fleischhacker D., Muntz H.G., Falkenberry S.S., Nikrui N., Fuller A.F. Jr.: Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 1993 Jul; 50 (1):105-109
15. Hardman M.P., Roman J.J., Burnett A.F., Santin A.D.: Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor. Obstet Gynecol 2007; 110:518-520
16. Hendrickson M.R., Tavassoli F.A., Kempson R.L., McCluggage W.G., Haller U., Kubik-Huch R.A.: Mesenchymal tumours and related lesions. In: Tavassoli F.A., Devilee P. (eds.). Tumours of the Breast and female genital organs. IARC Press, page 233-244; Lyon, 2003
17. Hensley M.L., Maki R., Venkatraman E., Geller G., Lovegren M., Aghajanian C., Sabbatini P., Tong W., Barakat R., Spriggs D.R.: Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002; 20:2824-2831
18. Jones M.W., Norris H.J.: Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol 1995; 14:243-249
19. Larson B., Silfversward C., Nilsson B., Pettersson F.: Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936–1981. Acta Oncol 1990; 29:185-191
20. Leitao M.M., Sonoda Y., Brennan M.F., Barakat R.R., Chi D.S.: Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol 2003; 91:209-212
21. Leitao M.M., Soslow R.A., Nonaka D., Olshen A.B., Aghajanian C., Sabbatini P., Dupont J., Hensley M., Sonoda Y., Barakat R.R., Anderson S.: Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 2004; 101:1455-1462
22. Leunen M., Breugelmans M., De Sutter P., Bourgain C., Amy J.: Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 2004; 95:769-771
23. Li N., Wu L.Y., Zhang H.T., An J.S., Li X.G., Ma S.K.: Treatment options in stage I endometrial stromal sarcoma: A retrospective analysis of 53 cases. Gynecol Oncol 2007
24. Lissoni A., Cormio G., Perego P., Gabriele A., Cantu M.G., Bratina G.: Conservative management of endometrial stromal sarcoma in young women. Int J Gynecol Cancer 1997; 7:364-367
25. Major F.J., Blessing J.A., Silverberg S.G., Morrow C.P., Creasman W.T., Currie J.L., Yordan E., Brady M.F.: Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 1993; 71:1702-1709
26. Muss H.B., Bundy B.N., DI Saia P.J., Homesley H.D., Fowler W.C., Creasman W., Yordan E.: Treatment of recurrent or advanced uterine sarcoma: a randomized trial of doxorubicin versus doxorubicin and cyclophosphamide: a phase III trial of the Gynecologic Oncology Group. Cancer 1985; 55:1648-1653
27. Nordal R.N., Kjorstad K.E., Stenwig A.E., Trope C.G.: Leiomyosarcoma and endometrial stromal sarcoma of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976-1985. Int J Gynecol Cancer 1993; 3:110-115
28. Okuno S., Edmonson J., Mahoney M., Buckner J.C., Frytak S., Galanis E.: Phase II trial of gemcitabine in advanced sarcomas. Cancer 2002; 94:3225-3229
29. Omura G.A., Blessing J.A., Major F.A.: A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 1985; 3:1240-1245
30. Omura G.A., Major F.J., Blessing J.A., Sedlacek T.V., Thigpen J.T., Creasman W.T., Zaino R.T.: A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 1983; 52:626-632
31. Parker W.H., Fu Y.S., Berek J.S.: Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994; 83:414-418
32. Peters W.A. 3rd, Howard D.R., Andersen W.A., Figge D.C.: Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol 1994; 83:1015-1020
33. Pecorelli S.: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 2009; 105:103-104
34. Petru E., Lück H.J., Stuart G., Gaffney D., Millan D., Vergote I.: Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol 2009; 143:69-74
35. Prat J.: FIGO staging for uterine sarcomas. Int J Gynecol Obstet 2009; 104:177-178
36. Sanfilippo R., Grosso F., Jones R.L. et al.: Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers. Gynecol Oncol 2011 Sep 12 (Epub ahead of print)
37. Reed N.S., Mangioni C., Malmstrom H. et al.: Phase III randomized study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an EORTC Gynaecological Cancer Group study (protocol 55874); manuscript in preparation
38. Reich O., Regauer S., Urdl W., Lahousen M., Winter R.: Expression of oestrogen and progesterone receptors in lowgrade endometrial stromal sarcomas. Br J Cancer 2000; 82:1030-1034
39. Reich O., Regauer S.: Hormonal therapy of endometrial stromal sarcoma. Curr Opin Oncol 2007; 19:347-352
40. Riopel J., Plante M., Renaud M.-C., Roy M., Têtu B.: Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol 2005; 96:402-406
41. Sutton G., Blessing J.A., Malfetano J.H.: Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 1996a; 62:226-229
42. Sutton G., Blessing J.A., Park R., DiSaia P.J., Rosenshein N.: Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. Obstet Gynecol 1996; 87:747-750
43. Sutton G.P., Blessing J.A., Barrett R.J., McGehee R.: Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1992; 166:556-559
44. Wade K., Quinn M.A., Hammond I., Williams K., Cauchi M.: Uterine sarcoma: steroid receptors and response to hormonal therapy. Gynecol Oncol 1990; 39:364-367
45. Weitmann H.D., Knocke T.H., Kucera H., Potter R.: Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 2001; 49:739-48